Convalescence begins
07/05/21 -"We have input the latest numbers from the full Annual Report 2020 on top of the €1.00 dividend per share. This has led to some minor changes here and there."
Pages
64
Language
English
Published on
07/05/21
You may also be interested by these reports :
10/08/26
In H1 26, the €19m growth in “recurring” profits was driven by the contribution from Development activities: +€16m in total. However, inventory ...
07/08/26
Despite the decline in our EPS estimates, our target price remains virtually unchanged. Indeed, following the sharp drop in like-for-like GAV in ...
06/08/26
H1 26 performance is weaker than the previous year. However, management confirms that the low end of the FY 26 guidance range is achievable.
06/08/26
H1 26 earnings indicate a temporary slowdown in organic growth and reduced momentum in the Residential Development sector. However, guidance for FY ...